STOCK TITAN

Director at Clarus (CLAR) granted 20,000 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Clarus Corp director Nicolas Sokolow received a grant of stock options covering 20,000 shares of common stock. The options have an exercise price of $3.11 per share and expire on May 28, 2036. They were granted under Clarus’ Amended and Restated 2015 Stock Incentive Plan.

The award vests in four equal installments of 5,000 options on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. Following this grant, Sokolow holds options to purchase 20,000 shares directly. This is a compensation-related grant rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider SOKOLOW NICOLAS
Role null
Type Security Shares Price Value
Grant/Award Stock Option (right to purchase) 20,000 $0.00 --
Holdings After Transaction: Stock Option (right to purchase) — 20,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Stock options granted 20,000 options Grant to director Nicolas Sokolow on May 28, 2026
Exercise price $3.11 per share Exercise price for Sokolow’s stock options
Options after transaction 20,000 options Total options held directly following the grant
Expiration date May 28, 2036 Option expiration for the 20,000-share grant
First vesting tranche 5,000 options Vest and become exercisable on June 30, 2026
Second vesting tranche 5,000 options Vest and become exercisable on September 30, 2026
Third vesting tranche 5,000 options Vest and become exercisable on December 31, 2026
Fourth vesting tranche 5,000 options Vest and become exercisable on March 31, 2027
Stock Option (right to purchase) financial
"security_title: Stock Option (right to purchase)"
Amended and Restated 2015 Stock Incentive Plan financial
"was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan"
Common Stock financial
"Issuer's common stock, $0.0001 par value per share (the "Common Stock")"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vest and become exercisable financial
"Options to purchase 5,000 shares ... will vest and become exercisable on each date"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SOKOLOW NICOLAS

(Last)(First)(Middle)
6020 SHORE BOULEVARD SOUTH, #801

(Street)
GULFPORT FLORIDA 33707

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Clarus Corp [ CLAR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to purchase)$3.1105/28/2026A20,000 (1)05/28/2036Common Stock20,000$020,000D
Explanation of Responses:
1. The option to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan. Options to purchase 5,000 shares of the Issuer's Common Stock will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, respectively.
/s/ Nicolas Sokolow06/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Clarus (CLAR) disclose about director Nicolas Sokolow in this Form 4?

Clarus disclosed that director Nicolas Sokolow received a grant of stock options covering 20,000 shares of common stock. These options were issued as a compensation-related award under the company’s Amended and Restated 2015 Stock Incentive Plan, not through open-market trading.

How many Clarus (CLAR) shares are covered by Nicolas Sokolow’s new stock options?

The new stock option grant to Nicolas Sokolow covers 20,000 shares of Clarus common stock. All 20,000 options are reflected as held directly after the transaction, providing potential future rights to acquire shares if the options vest and are exercised.

What is the exercise price and expiration date of the Clarus (CLAR) options granted to Nicolas Sokolow?

The options granted to Nicolas Sokolow have an exercise price of $3.11 per share and expire on May 28, 2036. This means he may choose to purchase Clarus common stock at $3.11 before that expiration date, subject to the vesting schedule.

How do the Clarus (CLAR) stock options granted to Nicolas Sokolow vest over time?

The 20,000 Clarus stock options vest in four equal installments of 5,000 options. Vesting dates are June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, meaning portions of the award become exercisable on each of those dates.

Under which plan were the Clarus (CLAR) stock options for Nicolas Sokolow granted?

The options were granted under Clarus Corporation’s Amended and Restated 2015 Stock Incentive Plan. This plan provides equity-based compensation awards, such as stock options, to directors and other eligible participants, aligning their interests with shareholders over the long term.